骨骼肌SIRT3缺陷通过LOXL2-CNPY2轴促进HFpEF相关肺血管重塑
该研究探讨骨骼肌SIRT3缺陷在射血分数保留的心力衰竭相关肺动脉高压(PH-HFpEF)肺血管重塑中的作用。通过骨骼肌特异性Sirt3敲除小鼠和蛋白质组学分析,发现SIRT3缺陷骨骼肌分泌LOXL2增加,通过CNPY2-p53信号促进肺血管细胞增殖和肺压升高;敲除骨骼肌Loxl2可改善高脂饮食诱导的PH-HFpEF小鼠肺压。研究提示骨骼肌SIRT3-LOXL2-CNPY2内分泌轴是潜在治疗靶点。
要点
- 骨骼肌SIRT3缺陷导致肺血管密度降低、增殖性重塑和肺压升高。
- SIRT3缺陷骨骼肌分泌LOXL2增加,通过CNPY2-p53信号促进肺血管细胞增殖。
- 骨骼肌特异性Loxl2敲除可改善高脂饮食诱导的PH-HFpEF小鼠肺压。
核心结论
- 骨骼肌SIRT3缺陷通过肌因子LOXL2远程调控肺血管CNPY2表达,促进肺血管重塑和PH-HFpEF。
- 骨骼肌SIRT3、LOXL2和CNPY2是PH-HFpEF的潜在治疗靶点。
研究设计与样本
- 使用骨骼肌特异性Sirt3敲除小鼠(Sirt3skm-/-)和基于质谱的分泌组比较分析。
- 在Sirt3skm-/-小鼠、PH-HFpEF大鼠模型和PH-HFpEF患者中检测LOXL2和CNPY2表达。
- 在高脂饮食诱导的PH-HFpEF小鼠中行骨骼肌特异性Loxl2敲除。
主要发现
- Sirt3skm-/-小鼠表现为肺血管密度降低、肺血管增殖性重塑和肺压升高。
- SIRT3缺陷骨骼肌细胞分泌LOXL2增加,Sirt3skm-/-小鼠血浆和骨骼肌、PH-HFpEF大鼠模型及PH-HFpEF患者中LOXL2循环和蛋白表达水平升高。
- Sirt3skm-/-小鼠和PH-HFpEF动物模型的肺动脉内皮细胞和平滑肌细胞中CNPY2表达增加,肥胖者肺动脉平滑肌细胞CNPY2水平高于非肥胖者。
- 重组LOXL2蛋白通过调控CNPY2-p53信号促进肺动脉内皮细胞迁移/增殖和肺动脉平滑肌细胞增殖。
- 骨骼肌特异性Loxl2缺失降低肺动脉内皮细胞和平滑肌细胞CNPY2表达,并改善高脂饮食诱导PH-HFpEF小鼠的肺压。
临床怎么用
- 骨骼肌SIRT3缺陷可作为PH-HFpEF肺血管重塑的远程调控因素进行认识。
- LOXL2和CNPY2可能作为PH-HFpEF的循环标志物或治疗靶点进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary hypertension (PH) is a major complication linked to adverse outcomes in heart failure with preserved ejection fraction (HFpEF), yet no specific therapies exist for PH associated with HFpEF (PH-HFpEF). We have recently reported on the role of skeletal muscle SIRT3 (sirtuin-3) in modulation of PH-HFpEF, suggesting a novel endocrine signaling pathway for skeletal muscle modulation of pulmonary vascular remodeling. METHODS: Using skeletal muscle-specific Sirt3 knockout mice (Sirt3skm-/-) and mass spectrometry-based comparative secretome analysis, we attempted to define the processes by which skeletal muscle SIRT3 defects affect pulmonary vascular health in PH-HFpEF. RESULTS: Sirt3skm-/- mice exhibited reduced pulmonary vascular density accompanied by pulmonary vascular proliferative remodeling and elevated pulmonary pressures. Comparative analysis of secretome by mass spectrometry revealed elevated secretion levels of LOXL2 (lysyl oxidase homolog 2) in SIRT3-deficient skeletal muscle cells. Elevated circulation and protein expression levels of LOXL2 were also observed in plasma and skeletal muscle of Sirt3skm-/- mice, a rat model of PH-HFpEF, and humans with PH-HFpEF. In addition, expression levels of CNPY2 (canopy fibroblast growth factor signaling regulator 2), a known proliferative and angiogenic factor, were increased in pulmonary artery endothelial cells and pulmonary artery smooth muscle cells of Sirt3skm-/- mice and animal models of PH-HFpEF. CNPY2 levels were also higher in pulmonary artery smooth muscle cells of subjects with obesity compared with nonobese subjects. Moreover, treatment with recombinant LOXL2 protein promoted pulmonary artery endothelial cell migration/proliferation and pulmonary artery smooth muscle cell proliferation through regulation of CNPY2-p53 signaling. Last, skeletal muscle-specific Loxl2 deletion decreased pulmonary artery endothelial cell and pulmonary artery smooth muscle cell expression of CNPY2 and improved pulmonary pressures in mice with high-fat diet-induced PH-HFpEF. CONCLUSIONS: This study demonstrates a systemic pathogenic impact of skeletal muscle SIRT3 deficiency in remote pulmonary vascular remodeling and PH-HFpEF. This study suggests a new endocrine signaling axis that links skeletal muscle health and SIRT3 deficiency to remote CNPY2 regulation in the pulmonary vasculature through myokine LOXL2. Our data also identify skeletal muscle SIRT3, myokine LOXL2, and CNPY2 as potential targets for the treatment of PH-HFpEF.
引用
- Jheng, Bai, Noda, et al. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction. Circulation. 2024. PMID: 38804138. doi:10.1161/CIRCULATIONAHA.124.068624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。